The characteristic 3-4 month delay between the triggering event and visible shedding occurs because follicles complete their current growth cycle before entering the telogen phase
References Vargas-Soria, M., Garcia-Alloza, M
Supplements are not intended to diagnose, treat, cure, or prevent any disease
Novo's not giving it to them
Although a triple agonist stimulant that includes GLP-1, GIP, and glucagon has shown promising results in animals and the early phase of the clinical trial in terms of weight and metabolic regulation
Patients initiating semaglutide therapy should anticipate gradual changes in appetite and eating patterns, typically beginning within the first two to four weeks of treatment